Literature DB >> 32449669

A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics.

Amit Lakhanpal1, Ernest Brahn2.   

Abstract

Entities:  

Year:  2020        PMID： 32449669      PMCID： PMC7431337          DOI： 10.5152/eurjrheum.2020.2065

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN： 2147-9720


× No keyword cloud information.
  38 in total

Review 1.  Targeting the "cytokine storm" for therapeutic benefit.

Authors:  Riccardo V D'Elia; Kate Harrison; Petra C Oyston; Roman A Lukaszewski; Graeme C Clark
Journal:  Clin Vaccine Immunol       Date:  2013-01-02

2.  The Rheumatologist's Role in COVID-19.

Authors:  Randy Q Cron; W Winn Chatham
Journal:  J Rheumatol       Date:  2020-03-24       Impact factor: 4.666

3.  On the use of corticosteroids for 2019-nCoV pneumonia.

Authors:  Lianhan Shang; Jianping Zhao; Yi Hu; Ronghui Du; Bin Cao
Journal:  Lancet       Date:  2020-02-12       Impact factor: 79.321

4.  What policy makers need to know about COVID-19 protective immunity.

Authors:  Daniel M Altmann; Daniel C Douek; Rosemary J Boyton
Journal:  Lancet       Date:  2020-04-27       Impact factor: 79.321

5.  Emil Behring's medical culture: from disinfection to serotherapy.

Authors:  Jonathan Simon
Journal:  Med Hist       Date:  2007-04       Impact factor: 1.419

6.  Bacillus Calmette-Guérin-Induced Trained Immunity Is Not Protective for Experimental Influenza A/Anhui/1/2013 (H7N9) Infection in Mice.

Authors:  L Charlotte J de Bree; Renoud J Marijnissen; Junda M Kel; Sietske K Rosendahl Huber; Peter Aaby; Christine Stabell Benn; Marcel V W Wijnands; Dimitri A Diavatopoulos; Reinout van Crevel; Leo A B Joosten; Mihai G Netea; John Dulos
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

7.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

8.  Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.

Authors:  Adarsh Bhimraj; Rebecca L Morgan; Amy Hirsch Shumaker; Valery Lavergne; Lindsey Baden; Vincent Chi-Chung Cheng; Kathryn M Edwards; Rajesh Gandhi; William J Muller; John C O'Horo; Shmuel Shoham; M Hassan Murad; Reem A Mustafa; Shahnaz Sultan; Yngve Falck-Ytter
Journal:  Clin Infect Dis       Date:  2020-04-27       Impact factor: 9.079

9.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Philippe Parola; Van Thuan Hoang; Line Meddeb; Morgane Mailhe; Barbara Doudier; Johan Courjon; Valérie Giordanengo; Vera Esteves Vieira; Hervé Tissot Dupont; Stéphane Honoré; Philippe Colson; Eric Chabrière; Bernard La Scola; Jean-Marc Rolain; Philippe Brouqui; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2020-03-20       Impact factor: 5.283

10.  Targeting potential drivers of COVID-19: Neutrophil extracellular traps.

Authors:  Betsy J Barnes; Jose M Adrover; Amelia Baxter-Stoltzfus; Alain Borczuk; Jonathan Cools-Lartigue; James M Crawford; Juliane Daßler-Plenker; Philippe Guerci; Caroline Huynh; Jason S Knight; Massimo Loda; Mark R Looney; Florencia McAllister; Roni Rayes; Stephane Renaud; Simon Rousseau; Steven Salvatore; Robert E Schwartz; Jonathan D Spicer; Christian C Yost; Andrew Weber; Yu Zuo; Mikala Egeblad
Journal:  J Exp Med       Date:  2020-06-01       Impact factor: 17.579
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.